GL1X · GenesisL1 explorer

Research workbench

Human EPHA3 kinase domain in complex with quinoxaline derivatives

Analyse Human EPHA3 kinase domain in complex with quinoxaline derivatives in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4P5Q
Type
protein
Length
275 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ephrin type-a receptor 3
EC
2.7.10.1
UniProt
P29320
Ligands
Q0B
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEphrin type-a receptor 3 (EC 2.7.10.1)protein27540% helix, 18% strandP29320

Ligands and binding sites

  • Q0B · 2-amino-1-(2-chlorophenyl)-N-(3-ethoxypropyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12800.580.7833Q0B

Compared structures

  • 4P5Q · Human EphA3 Kinase domain in complex with quinoxaline derivatives · the same entry in another collection · chain A against A, TM-score 1.00
  • P29320 · AlphaFold monomer V2.0 prediction for ephrin type-a receptor 3 (P29320) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.